149 related articles for article (PubMed ID: 25330222)
1. Allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome.
Nishihori T; Komrokji R; Shain K; Anasetti C
Bone Marrow Transplant; 2015 Feb; 50(2):296-7. PubMed ID: 25330222
[No Abstract] [Full Text] [Related]
2. Reply to 'allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome'.
Schroeder T; Fenk R; Haas R; Germing U; Kobbe G
Bone Marrow Transplant; 2015 Nov; 50(11):1483-5. PubMed ID: 26237167
[No Abstract] [Full Text] [Related]
3. Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma.
Nadiminti K; Sidiqi MH; Meleveedu K; Alkhateeb HB; Hogan WJ; Litzow M; Patnaik M; Kumar S; Gertz M; Chen D; Shah MV
Blood Cancer J; 2021 Mar; 11(3):63. PubMed ID: 33741897
[No Abstract] [Full Text] [Related]
4. Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myeloma.
Duong VH; Holtzman NG; Koka R; Singh ZN; Zou Y; Emadi A; Rapoport AP; Kocoglu MH; Baer MR; Badros AZ
Leuk Lymphoma; 2019 Dec; 60(14):3577-3580. PubMed ID: 31282234
[No Abstract] [Full Text] [Related]
5. Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancy.
Zimmerman Z; Scott BL; Gopal AK; Sandmaier BM; Maloney DG; Deeg HJ
Bone Marrow Transplant; 2012 Jun; 47(6):804-9. PubMed ID: 21909142
[TBL] [Abstract][Full Text] [Related]
6. Progressive Hepatic Cirrhosis Early After Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Chronic Hepatitis C Infection.
Kaito S; Doki N; Hishima T; Takaki Y; Ohashi K
Turk J Haematol; 2019 May; 36(2):130-133. PubMed ID: 30717587
[No Abstract] [Full Text] [Related]
7. Feasibility of myeloablative allogeneic hematopoietic cell transplantation from unrelated donors for patients with relapsed or refractory multiple myeloma.
Shingaki S; Tsukada N; Ishida T; Suzuki K
Hematol Oncol; 2018 Feb; 36(1):363-365. PubMed ID: 28791712
[No Abstract] [Full Text] [Related]
8. [Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk myelodysplastic syndrome].
Maeda Y
Rinsho Ketsueki; 2014 Oct; 55(10):1870-81. PubMed ID: 25297751
[No Abstract] [Full Text] [Related]
9. [Stem cells in hematology and oncology].
Goldschmidt H; Egerer G; Fruehauf S; Ho AD
Med Klin (Munich); 2003 Dec; 98 Suppl 2():11-4. PubMed ID: 14992195
[TBL] [Abstract][Full Text] [Related]
10. Variation in inpatient costs of hematopoietic cell transplantation among transplant centers in the United States.
Thao V; Kozhimannil KB; Thomas W; Golberstein E
JAMA Intern Med; 2014 Aug; 174(8):1409-12. PubMed ID: 24934623
[No Abstract] [Full Text] [Related]
11. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic state.
Rashidi A; Ali AM; Vij KR; Shanley R; Romee R; Cooley SA; Westervelt P; DiPersio JF; Miller JS; Weisdorf DJ; Ustun C
Am J Hematol; 2017 Sep; 92(9):E549-E552. PubMed ID: 28568483
[No Abstract] [Full Text] [Related]
13. A fatal Clostridium infection in an allogeneic stem cell transplant recipient.
Jain M; Titanji R; Rapoport AP; Wang W; Gocke C; Cross A; Akpek G
Bone Marrow Transplant; 2005 Sep; 36(5):455-7. PubMed ID: 15995716
[No Abstract] [Full Text] [Related]
14. Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation.
Gonçalves TL; Benvegnú DM; Bonfanti G
Oxid Med Cell Longev; 2009; 2(2):82-7. PubMed ID: 20357929
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic stem cell transplantation in hematologic malignancy.
Archuleta TD; Devetten MP; Armitage JO
Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
[TBL] [Abstract][Full Text] [Related]
16. Current awareness in hematological oncology.
Hematol Oncol; 1995; 13(1):49-58. PubMed ID: 7750928
[No Abstract] [Full Text] [Related]
17. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases.
Slavin S; Nagler A; Naparstek E; Kapelushnik Y; Aker M; Cividalli G; Varadi G; Kirschbaum M; Ackerstein A; Samuel S; Amar A; Brautbar C; Ben-Tal O; Eldor A; Or R
Blood; 1998 Feb; 91(3):756-63. PubMed ID: 9446633
[TBL] [Abstract][Full Text] [Related]
18. Monosomy 7 in Pediatric Myelodysplastic Syndromes.
Wlodarski MW; Sahoo SS; Niemeyer CM
Hematol Oncol Clin North Am; 2018 Aug; 32(4):729-743. PubMed ID: 30047423
[TBL] [Abstract][Full Text] [Related]
19. Reduced-intensity and nonmyeloablative conditioning regimens.
Foss F; van Besien K
Cancer Treat Res; 2009; 144():209-32. PubMed ID: 19779868
[No Abstract] [Full Text] [Related]
20. The role of hypomethylating agents prior to hematopoietic cell transplantation in myelodysplastic syndromes.
Sekeres MA
Best Pract Res Clin Haematol; 2018 Dec; 31(4):346-350. PubMed ID: 30466745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
